Total Payments
$22,959
2024 Payments
$15.22
Companies
10
Transactions
25
Medicare Patients
197
Medicare Billing
$17,040
Payment Breakdown by Category
Consulting$11,713 (51.0%)
Other$9,267 (40.4%)
Travel$1,225 (5.3%)
Food & Beverage$753.79 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,713 | 3 | 51.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,267 | 5 | 40.4% |
| Travel and Lodging | $1,225 | 5 | 5.3% |
| Food and Beverage | $753.79 | 12 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $9,267 | 5 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $7,975 | 2 | $0 (2020) |
| GENZYME CORPORATION | $5,301 | 9 | $0 (2021) |
| Biogen, Inc. | $183.60 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $90.37 | 1 | $0 (2017) |
| EMD Serono, Inc. | $51.32 | 2 | $0 (2024) |
| Actelion Pharmaceuticals, Ltd | $42.83 | 1 | $0 (2017) |
| Genentech USA, Inc. | $22.37 | 1 | $0 (2017) |
| Genentech, Inc. | $13.09 | 1 | $0 (2019) |
| AbbVie Inc. | $12.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.22 | 1 | EMD Serono, Inc. ($15.22) |
| 2021 | $133.75 | 2 | GENZYME CORPORATION ($120.93) |
| 2020 | $4,125 | 1 | Teva Pharmaceuticals USA, Inc. ($4,125) |
| 2019 | $10,390 | 10 | F. Hoffmann-La Roche AG ($5,270) |
| 2018 | $95.58 | 1 | Biogen, Inc. ($95.58) |
| 2017 | $8,200 | 10 | F. Hoffmann-La Roche AG ($3,997) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| 09/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $120.93 | General |
| 12/16/2020 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| Category: Central Nervous System | ||||||
| 10/08/2019 | Genentech, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Consulting Fee | Cash or cash equivalent | $3,738.00 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Travel and Lodging | In-kind items and services | $601.71 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Travel and Lodging | In-kind items and services | $393.80 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Travel and Lodging | In-kind items and services | $173.83 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $107.02 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Travel and Lodging | Cash or cash equivalent | $37.95 | General |
| 09/12/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Travel and Lodging | Cash or cash equivalent | $18.00 | General |
| 05/28/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: Neurology | ||||||
| 03/31/2019 | F. Hoffmann-La Roche AG | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $5,270.27 | General |
| Category: Immunology | ||||||
| 09/19/2018 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.58 | General |
| 10/27/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $88.02 | General |
| Category: NEUROLOGY | ||||||
| 10/27/2017 | Actelion Pharmaceuticals, Ltd | — | Food and Beverage | In-kind items and services | $42.83 | General |
| 10/26/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 09/24/2017 | Teva Pharmaceuticals USA, Inc. | LAQUINIMOD (Drug) | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| Category: Central Nervous System | ||||||
| 06/30/2017 | F. Hoffmann-La Roche AG | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,964.03 | General |
| Category: Immunology | ||||||
| 06/30/2017 | F. Hoffmann-La Roche AG | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,108.64 | General |
| Category: Immunology | ||||||
| 04/24/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $109.44 | General |
| 04/22/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $90.37 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2017 | F. Hoffmann-La Roche AG | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $521.28 | General |
| Category: Immunology | ||||||
| 03/31/2017 | F. Hoffmann-La Roche AG | OCREVUS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $402.75 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 5 | 197 | 230 | $40,982 | $17,040 |
Total Patients
197
Total Services
230
Medicare Billing
$17,040
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 109 | $19,907 | $7,864 | 39.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $8,740 | $3,380 | 38.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $5,783 | $2,524 | 43.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $4,074 | $1,968 | 48.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 21 | 42 | $2,478 | $1,304 | 52.6% |
About Dr. Michael Racke, MD
Dr. Michael Racke, MD is a Neurology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821052721.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Racke, MD has received a total of $22,959 in payments from pharmaceutical and medical device companies, with $15.22 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($11,713).
As a Medicare-enrolled provider, Racke has provided services to 197 Medicare beneficiaries, totaling 230 services with total Medicare billing of $17,040. Data is available for 1 year (2020–2020), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Columbus, OH
- Active Since 04/17/2006
- Last Updated 12/01/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1821052721
Products in Payments
- OCREVUS (Biological) $9,280
- DISEASE STATE (Drug) $5,070
- COPAXONE (Drug) $4,125
- LAQUINIMOD (Drug) $3,850
- NO PRODUCT DISCUSSED (Drug) $109.44
- GILENYA (Drug) $90.37
- TYSABRI (Biological) $88.02
- Mavenclad (Biological) $36.10
- UBRELVY (Drug) $12.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Columbus
Kenneth Mankowski, Do, DO
Neurology — Payments: $1.9M
Neurology $1.9M
Dr. Aaron Boster, Md, MD
Neurology — Payments: $1.9M
Neurology $1.9M
Danielle Becker, Md, MD
Neurology — Payments: $1.3M
Neurology $1.3M
Dr. Jacqueline Nicholas, M.d, M.D
Neurology — Payments: $967,203
Neurology $967,203
Dr. Jonathan Liss, M.d, M.D
Neurology — Payments: $468,143
Neurology $468,143
Jerry Mendell, Md, MD
Neurology — Payments: $371,804
Neurology $371,804